Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation

American Journal of Cardiology

Volumn 97, Issue 5, 2006, Pages 659-661

  Hatzinikolaou Kotsakou, Eleni ^a   Tziakas, Dimitrios ^a   Hotidis, Athanasios ^a   Stakos, Dimitrios ^a   Floros, Dimitrios ^a   Papanas, Nikolaos ^a   Chalikias, Georgios ^a   Maltezos, Efstratios ^a   Hatseras, Dimitrios Ioanni ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; C REACTIVE PROTEIN;

ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK;

AGE FACTORS; ANALYSIS OF VARIANCE; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RECURRENCE;

EID: 32844470917     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.09.104     Document Type: Article

References (13)

1. M.K. Chung, D.O. Mart, D. Sprecher, O. Wazni, A. Kanderian, C.A. Carnes, J.A. Bauer, P.J. Tchou, M.J. Niebauer, A. Natale, D.R. Wagoner C-reactive protein elevation in patients with atrial fibrillation inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 2001 2886 2891
2. D.S. Conway, P. Buggins, E. Hughes, G.Y. Lip Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation Am Heart J 148 2004 462 466
3. A.J. Sanfilippo, V.M. Abasca, M. Sheeham, L.B. Oertel, P. Harrigan, R.A. Hughes, A.E. Weyman Atrial enlargement as a consequence of atrial fibrillation a prospective echocardiographic study Circulation 83 1990 792 797
4. M.J. Mihm, F. Yu, C.A. Carnes, P.J. Reiser, P.M. McCarthy, D.R. Van Wagoner, J.A. Bauer Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation Circulation 104 2001 174 180
5. U. Schotten, J. Ausma, C. Stellbrink, I. Sabatschus, M. Vogel, D. Freschen, F. Schoendube, P. Hanrath, M.A. Allessie Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation Circulation 103 2001 691 698
6. H. Sun, R. Gaspo, N. Leblanc, S. Nattel Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia Circulation 98 1998 719 727
7. J. Feng, R. Gaspo, G.R. Li, Z. Wang, S. Nattel Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation Circ Res 81 1997 512 525
8. 2+ currents and human atrial fibrillation Circ Res 85 1999 428 436
9. P. Bruins, H. te Velthuis, A.P. Yazdanbakhsh, P.G. Jansen, F.W. vanHardevelt, E.M. de Beaumont, C.R. Wildevuur, L. Eijsman, A. Trouwborst, C.E. Hack Activation of the complement system during and after cardiopulmonary bypass surgery postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia Circulation 96 1997 3542 3548
10. M.L. Fontes, J.P. Mathew, H.M. Rinder, D. Zelterman, B.R. Smith, C.S. Rinder Multicenter Study of Perioperative Ischemia (McSPI) Research Group Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation Anesth Analg 101 2005 17 23
11. F.C. Luf Angiotensin, inflammatory, hypertension, and cardiovascular disease Curr Hypertens Rep 3 2001 61 67
12. P.M. Ridker, M. Cushman, M.J. Stampfe, R.P. Tracy, C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
13. R.R. Azar, S. Rinfret, P. Theroux, P.H. Stone, R. Dakshinamurthy, Y.J. Feng, A.H. Wu, G. Range, D.D. Waters A randomized placebo-controlled trial to assess the efficacy of anti-inflammatory therapy with methylprednisolone in unstable angina (MUNA trial) Eur Heart J 21 2000 2026 2032